Benzinga - Tue, 23 Feb 2021 17:37:20 -0400
Benzinga - Tue, 23 Feb 2021 13:37:35 -0400
Benzinga - Tue, 23 Feb 2021 13:33:56 -0400
Benzinga - Tue, 23 Feb 2021 13:18:58 -0400
Benzinga - Tue, 23 Feb 2021 09:08:06 -0400
Benzinga - Tue, 23 Feb 2021 08:02:48 -0400
Benzinga - Mon, 22 Feb 2021 09:08:01 -0400
load more
Sector: Health Care.Industry: Biotechnology
Vascular Biogenics Ltd is an Israel-based clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-13
REV
Q4 2020Est.ActualSurprise
EPS
(EXPECTED)2021-03-18
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
VBLTVascular Biogenics1.12%87.2M

Vascular Biogenics Company Questions & Answers

Q

How do I buy Vascular Biogenics (VBLT) stock?

A

You can purchase shares of Vascular Biogenics (NASDAQ: VBLT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Vascular Biogenics's (VBLT) main competitors?

A

Other companies in Vascular Biogenics’s space includes: Advaxis (NASDAQ:ADXS), Allena Pharmaceuticals (NASDAQ:ALNA) and Cleveland BioLabs (NASDAQ:CBLI).

Q

What is the target price for Vascular Biogenics?

A

The latest price target for Vascular Biogenics (NASDAQ: VBLT) was reported by HC Wainwright & Co. on 2021-01-28. The analyst firm set a price target for 4.00 expecting VBLT to rise to within 12 months (a possible 120.99% upside). 2 analyst firms have reported ratings in the last year.

Q

How much is Vascular Biogenics (VBLT) stock ?

A

The stock price for Vascular Biogenics (NASDAQ: VBLT) is $1.81 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next Vascular Biogenics (VBLT) dividend?

A

There are no upcoming dividends for Vascular Biogenics.

Q

When is Vascular Biogenics (NASDAQ:VBLT) reporting earnings?

A
Vascular Biogenics’s Q1 earnings are confirmed from now on May 13, 2021.
Q

When is the upcoming split for VBLT?

A

There is no upcoming split for Vascular Biogenics.